临床药师对1例超低出生体质量早产儿合并代谢性骨病的药学监护

马云霞; 朱琳; 杨蕾; 李智平

doi:10.13407/j.cnki.jpp.1672-108X.2022.10.003

您当前的位置：

首页 >

文章列表页 >

临床药师对1例超低出生体质量早产儿合并代谢性骨病的药学监护

论著 | 更新时间：2022-11-04

- 临床药师对1例超低出生体质量早产儿合并代谢性骨病的药学监护
- Pharmaceutical Care for a Case of Extremely Low Birth Weight Preterm Infant with Metabolic Bone Disease by Clinical Pharmacists
- 儿科药学杂志 2022年28卷第10期页码：10-14
- 作者机构：
  
  1. 国家儿童医学中心, 复旦大学附属儿科医院,上海,201102
  2. 玉溪市儿童医院,云南,玉溪,653100
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2022.10.003
  中图分类号：
- 纸质出版日期：2022，
扫描看全文
马云霞, 朱琳, 杨蕾, 等. 临床药师对1例超低出生体质量早产儿合并代谢性骨病的药学监护[J]. 儿科药学杂志, 2022,28(10):10-14.

Ma Yunxia, Zhu Lin, Yang Lei, et al. Pharmaceutical Care for a Case of Extremely Low Birth Weight Preterm Infant with Metabolic Bone Disease by Clinical Pharmacists[J]. 2022,28(10):10-14.
马云霞, 朱琳, 杨蕾, 等. 临床药师对1例超低出生体质量早产儿合并代谢性骨病的药学监护[J]. 儿科药学杂志, 2022,28(10):10-14. DOI： 10.13407/j.cnki.jpp.1672-108X.2022.10.003.

Ma Yunxia, Zhu Lin, Yang Lei, et al. Pharmaceutical Care for a Case of Extremely Low Birth Weight Preterm Infant with Metabolic Bone Disease by Clinical Pharmacists[J]. 2022,28(10):10-14. DOI： 10.13407/j.cnki.jpp.1672-108X.2022.10.003.

摘要

目的：探讨临床药师参与1例超低出生体质量早产儿合并代谢性骨病的钙、磷补充及个体化肠外营养方案制定的切入点。方法：临床药师参与1例超低出生体质量早产儿合并代谢性骨病患儿的治疗过程，并对治疗方案与监测指标进行分析和总结。结果：结合患儿病理生理特点和病情进展，临床药师对患儿肠外营养钙、磷补充及维生素D添加提出药学建议，参与肠外营养个体化用药方案制定，促进疾病转归。结论：临床药师从药学角度参与早产儿个体化药物治疗，尤其是是肠外营养方案的优化及加强代谢性骨病相关药学监护，在促进临床合理用药、改善患儿预后方面发挥积极作用。

Abstract

Objective: To explore the entry points of clinical pharmacists to participate into the calcium and phosphorus supplementation and individualized parenteral nutrition programs for extremely low birth weight (ELBW) preterm infants with metabolic bone disease. Methods: Clinical pharmacists participated into the treatment process of an ELBW preterm infant with metabolic bone disease

the treatment regimen and monitoring indicators were analyzed and summarized. Results: Combined with the pathophysiological characteristics and disease progression of the infant

clinical pharmacists provided pharmaceutical suggestions for calcium

phosphorus and vitamin D supplementation of parenteral nutrition in children

participated into the formulation of individualized parenteral nutrition programs

and promoted the disease outcomes. Conclusion: Clinical pharmacists participate into the individualized drug treatment of preterm infant from the perspective of pharmacy

especially the optimization of parenteral nutrition programs and the strengthening of pharmaceutical care related to metabolic bone disease

which play an active role in promoting clinical rational drug use and improving the prognosis of children.

关键词

超低出生体质量早产儿代谢性骨病药学监护

Keywords

extremely low birth weightpreterm infantsmetabolic bone diseasepharmaceutical care

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

1 例肾病综合征合并药物性肝损伤患儿的药学监护

儿童精神类药物中毒的救治及药学监护

临床药师对利妥昔单抗治疗儿童激素依赖型肾病综合征的药学监护

英夫利昔单抗联合硫唑嘌呤治疗儿童克罗恩病的药学监护

1例布洛芬引起儿童肝衰竭病例分析